Login / Signup

A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease.

Gunnar BrinkmalmSimon SjödinAnja Hviid SimonsenSteen Gregers HasselbalchHenrik ZetterbergAnn BrinkmalmKaj Blennow
Published in: Proteomics. Clinical applications (2017)
PRM-MS of protein panels is a valuable tool to evaluate biomarker candidates for neurodegenerative disorders.
Keyphrases
  • mass spectrometry
  • multiple sclerosis
  • ms ms
  • cognitive decline
  • protein protein
  • amino acid
  • binding protein
  • human health
  • cerebrospinal fluid
  • mild cognitive impairment
  • climate change